N-BUTYLETHANOLAMINE (BTLETANOLAMN)

N-butylethanolamine

SYNONYMS; 2-(Butylamino)ethanol; 2-Butylaminoethanol; 111-75-1; N-Butylethanolamine; Ethanol, 2-(butylamino)-; n-Butylaminoethanol; Butylmonoethanolamine; BÜTL ETHANOL AMN; BÜTL AMN ETHANOL; N-Butyl monoethanolamine; 2-(N-Butylamino)ethanol; Butylethanalamine; BUTLEN AMN; Butyl(2-hydroxyethyl)amine; 2-(N-Monobutylamino)ethanol;

N-n-Butylethanolamine; 2-n-Butylaminoethanol; BÜTL AMNO; UNII-3IBO99KPV6; NSC 1098;

2-butylamino-ethanol; EINECS 203-904-5; 2-(butylamino)ethan-1-ol; AMN ETHANOL; BRN 1732522; N-BUTL; 3IBO99KPV6; Ethanol,2-(butylamino)-; N-Butyl-2-hydroxyethylamine; ethanol-n-butylamine; ETHANOL; Hydroxyethylbutylamine; 2-(butylamino)-ethanol; BÜTL AMN; 2-(n-butylamino)-ethanol; ACMC-2099al; EC 203-904-5; SCHEMBL42800; ETHANOL AMN; 3-04-00-00682 (Beilstein Handbook Reference); KSC507I8J; BUTLEN; WLN: Q2M4; N-butyl,N-2-; BUTHYL; hydroxyethylamine; DTXSID9059410; CTK4A7484; BUTHYLETHANOL; KS-00000YUZ; LJDSTRZHPWMDPG-UHFFFAOYSA-; BUTHYL AMNE; BCP5555; NSC1098; 2-(Butylamino)ethanol, >=98%; N-BUTHYL; NSC-1098; ZINC1587838; ETHANOLAMINE; ANW-16315; AKOS000120959;

MCULE-3582031814; NE10809; LS-66532; N-Butylethanolamine;Ethanol, 2-(butylamino)-; BUTHYL AMINE ETHANOL; W-109415; Q27257261; BUTHYL ETHANOL AMINE; ; 2-(Butylamino)ethanol; 2-Butylaminoethanol; 111-75-1; N-Butylethanolamine; Ethanol, 2-(butylamino)-; n-Butylaminoethanol; Butylmonoethanolamine; BÜTL ETHANOL AMN; BÜTL AMN ETHANOL; N-Butyl monoethanolamine; 2-(N-Butylamino)ethanol; Butylethanalamine; BUTLEN AMN; Butyl(2-hydroxyethyl)amine; 2-(N-Monobutylamino)ethanol;

N-n-Butylethanolamine; 2-n-Butylaminoethanol; BÜTL AMNO; UNII-3IBO99KPV6; NSC 1098;

MCULE-3582031814; NE10809; LS-66532; N-Butylethanolamine;Ethanol, 2-(butylamino)-; BUTHYL AMINE ETHANOL; W-109415; Q27257261; BUTHYL ETHANOL AMINE; 2-(BUTYLAMINO)ETHANOL;

2-(BUTYLAMINO)-ETHANOL; N-Butylethanolamine; Ethanol, 2-(butylamino)-; 2-(ButylaMino)ethanol; 2-(N-Monobutylamino)ethanol; 2-Butylaminoethanol; 2-n-Butylaminoethanol; Butyl(2-hydroxyethyl)amine; Butylethanolamine; Butylmonoethanolamine; N-Butyl monoethanolamine; n-Butylaminoethanol; n-Butylethanolamine; N-Butylethanolamine; Ethanol, 2-(butylamino)-; [ChemIDplus] N-Butyl-2-hydroxyethylamine; [Sigma-Aldrich MSDS] UN2735; Ethanol,2,2′-(butylimino)di- (6CI,7CI,8CI); 2,2′-(Butylimino)bis[ethanol]; 2,2′-(Butylimino)diethanol; 3-Butyl-3-aza-1,5-pentanediol; BIDE; Bis(b-hydroxyethyl)butylamine; Butylbis(2-hydroxyethyl)amine; Butyldiethanolamine; Diethanol(n-butyl)amine; N,N-Bis(2-hydroxyethyl)butylamine; N-Butyl-2,2′-iminodiethanol; N-Butyl-N,N-bis(2-hydroxyethyl)amine; N-Butyl-N,N-bis(hydroxyethyl)amine; N-Butyldiethanolamine; N-Butyliminodiethanol; N-n-Butyldiethanolamine; NSC60214; n-Butylethanolamine; n-Butylaminoethanol; 2-(butylamino)ethanol; Ethanol, 2-(butylamino)-; Bütiletanolamin; BÜTETANOL AMN ; bütil etanolamin; bütiletanol amin; bütil etanol amin; Bütiletanolamin; butiletanol amin; butil etanolamin; Bütil ethanol amin; Bütil Ethanol Amin; BÜTL ETHANOL AMN; Bütiletanolamin; BMEA, N-BEA, N-Butylethanolamin,; 2 Butylaminoethanol, Butyl(2-Hydroxyethy1)amine; Cas; No: 111-75-1; 2-(N-butylamino)ethanol; butylethanolamine; 2-(Butylamino)ethanol; N-Butylethanolamine; 2-Butylaminoethanol; n-Butylaminoethanol; Ethanol, 2-(butylamino)-; 111-75-1; Butylmonoethanolamine; N-Butyl monoethanolamine; 2-(N-Butylamino)ethanol; N-n-Butylethanolamine; Butylethanalamine; Butyl(2-hydroxyethyl)amine; 2-(N-Monobutylamino)ethanol; 2-n-Butylaminoethanol; NSC 1098; Ethanol,2-(butylamino)-; 2-(butylamino)ethan-1-ol; N-Butyl-2-hydroxyethylamine; ceshi;ceshis;Butylethanolamine ;butylethanalamine; Buthylethanolamine; 2-butylamino-ethano;n-Butylaminoethanol;N BUTYLETHANOLAMINE;Butylmonoethanolamin; ETHANOL-N-BUTYLAMINE2-(Butylamino)ethanol; 2-Butylaminoethanol; 111-75-1; N-Butylethanolamine; Ethanol, 2-(butylamino)-; n-Butylaminoethanol; Butylmonoethanolamine; N-Butyl monoethanolamine; 2-(N-Butylamino)ethanol; Butylethanalamine; Butyl(2-hydroxyethyl)amine; 2-(N-Monobutylamino)ethanol; N-n-Butylethanolamine; 2-n-Butylaminoethanol; UNII-3IBO99KPV6; NSC 1098; 2; butylamino-ethanol; EINECS 203-904-5; 2-(butylamino)ethan-1-ol; Ethanol,2-(butylamino)-N-Butyl-2-hydroxyethylamine; ethanol-n-butylamine; Hydroxyethylbutylamine; 2-(butylamino)-ethanol; 2-(n-butylamino)-ethanol; 2-(Butylamino)ethanol; 2-Butylaminoethanol; 111-75-1; N-Butylethanolamine; Ethanol, 2-(butylamino)-; n-Butylaminoethanol; Butylmonoethanolamine; N-Butyl monoethanolamine; 2-(N-Butylamino)ethanol; : BMEA, N-BEA, N-Butylethanolamin, 2-Butylaminoethanol, Butyl(2-Hydroxyethy1)amine; Butylethanalamine; Butyl(2hydroxyethyl) amine; 2-(N-Monobutylamino)ethanol; N-n-Butylethanolamine; 2-n-Butylaminoethanol; UNII-3IBO99KPV6; NSC 1098; 2; butylamino-ethanol; EINECS 203-904-5; 2-(butylamino)ethan-1-ol; Ethanol,2-(butylamino)-N-Butyl-2-hydroxyethylamine; ethanol-n-butylamine; Hydroxyethylbutylamine; 2-(butylamino)-ethanol;Bütiletanolamin; BÜTETANOL AMN ; bütil etanolamin; bütiletanol amin; bütil etanol amin; Bütiletanolamin; butiletanol amin; butil etanolamin; Bütil ethanol amin; Bütil Ethanol Amin; BÜTL ETHANOL AMN; Bütiletanolamin; BMEA, N-BEA, N-Butylethanolamin,; 2 Butylaminoethanol, Butyl(2-Hydroxyethy1)amine; Cas; No: 111-75-1; 2-(N-butylamino)ethanol; butylethanolamine; 2-(Butylamino)ethanol; N-Butylethanolamine; 2-Butylaminoethanol; n-Butylaminoethanol; Ethanol, 2-(butylamino)-; 111-75-1; Butylmonoethanolamine; N-Butyl monoethanolamine; 2-(N-Butylamino)ethanol; N-n-Butylethanolamine; Butylethanalamine; Butyl(2-hydroxyethyl)amine; 2-(N-Monobutylamino)ethanol; 2-n-Butylaminoethanol; NSC 1098; Ethanol,2-(butylamino)-; 2-(butylamino)ethan-1-ol; N-Butyl-2-hydroxyethylamine; ceshi;ceshis;Butylethanolamine ;butylethanalamine; Buthylethanolamine; 2-butylamino-ethano;n-Butylaminoethanol;N BUTYLETHANOLAMINE;Butylmonoethanolamin; ETHANOL-N-BUTYLAMINE2-(Butylamino)ethanol; 2-Butylaminoethanol; 111-75-1; N-Butylethanolamine; Ethanol, 2-(butylamino)-; n-Butylaminoethanol; Butylmonoethanolamine; N-Butyl monoethanolamine; 2-(N-Butylamino)ethanol; Butylethanalamine; Butyl(2-hydroxyethyl)amine; 2-(N-Monobutylamino)ethanol; N-n-Butylethanolamine; 2-n-Butylaminoethanol; UNII-3IBO99KPV6; NSC 1098; 2; butylamino-ethanol; EINECS 203-904-5; 2-(butylamino)ethan-1-ol; Ethanol,2-(butylamino)-N-Butyl-2-hydroxyethylamine; ethanol-n-butylamine; 2-(n-butylamino)-ethanol; BUTYLETHANOLAMINE; BUTYLETHANOLAMiNE; BUTYL ETHANOLAMINE; BUTYLETHANOLAMiNE; BÜTLETANOLAMN; BUTYLETHANOLAMIN; BÜTL ETANOLAMN; BÜTLETANOL AMN; BÜTL ETANOL AMN; BUTLETANOLAMN; BUTLETANOL AMN; BUTL ETANOLAMN; Butylethanolamne; Butylethanolamine; Butyl Ethanolamne; Butylethanolamine; Bütiletanolamin; Butylethanolamn; Bütil Etanolamin; Bütiletanol Amin; Bütiletanolamin; Bütil Etanol Amin; Bütiletanolamin; Butiletanol Amin; Butil Etanolamin; butylethanolamne; butylethanolamine; butyl ethanolamne; butylethanolamine; bütiletanolamin; butylethanolamn; bütil etanolamin; bütiletanol amin; bütil etanol amin; Bütiletanolamin; butiletanol amin; butil etanolamin; Bütil ethanol amin; Bütil Ethanol Amin; BÜTL ETHANOL AMN; Bütiletanolamin; BÜTLETANOLAMN

General description

N-Butyldiethanolamine (N-n-butyldiethanolamine) is a tertiary amine. It acts as an N-substituted diethanolamine ligand. It reacts with chromium(II) and lanthanide(III)/rare earth salts (Ln = La, Ce, Pr, Nd, Sm, Eu, Gd, Tb, Dy, Ho, Er, Tm, Yb, Lu, Y) in the presence of coligands to afford three series of isostructural 1:1 3d(Cr(III))/4f(Ln(III)) coordination cluster compounds.[

Application

N-Butyldiethanolamine (H2bdea, N-n-butyldiethanolamine) has been used in the synthesis of the following complexes (Hdnba = 3,5-dinitrobenzoic acid, Hpta = p-toluic acid, H2tpa = terephthalic acid):

• new mononuclear [Cu(Hbdea)2]·2Hdnba , dinuclear [Cu2(µ-Hbdea)2(N3)2] and [Cu2(µ-Hbdea)2(pta)2]·2H2O[1]

• 1D polymeric [Cu2(µ-Hbdea)2(µ-tpa)]n·2nH2O copper(II) compounds[1]

• tetranuclear 3d-4f single-molecule magnet (SMM) complexes[2]

Formula: C8H19NO2

CAS: 102-79-4

Description: N-Butyldiethanolamine is a colorless to yellow liquid with an amine-like odor. It is miscible with water in all proportions.

Synonyms: BDEA, N-Butyldiethanolamin, Butyldiethanolamin, Butyldiethanolamine, N,N-Bis(2-hydroxyethyl)Butylamine, N-Butyl-2,2’-iminodiethanol, N-Butyldiethanolamine, N-Butyliminodiethanol

Applications: Intermediate used in the production of Pharmaceuticals and Photographic chemical

Information provided by BASF

Product description

N-Butyldiethanolamine (BDEA) is available as a colorless to light yellow liquid with a slight odor. BDEA has a very low vapor pressure.

BDEA is an ideal neutralizing agent in systems required to be very low in odor.

N-Butylethanolamine (CAS 111-75-1) Market Research Report 2020 presents comprehensive data on N-Butylethanolamine markets globally and regionally (Europe, Asia, North America etc.)

The report includes N-Butylethanolamine description, covers its application areas and related patterns. It overviews N-Butylethanolamine market, names N-Butylethanolamine producers and indicates its suppliers.

Besides, the report provides N-Butylethanolamine prices in regional markets.

In addition to the above the report determines N-Butylethanolamine consumers in the market.

BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS).

We can analyze the following elements for each chemical product in any country or region:

• capacities and production

• consumption volume and structure

• market price trends

• exports and imports

• existing technologies

• feedstock market condition

• market news digest

• market forecast.

N-Butylethanolamine (CAS 111-75-1) Market Research Report 2020 can feature:

• market condition and estimations, market forecast

• chemical product ranges, trademarks, analogous products, application areas

• regional and global producers, consumers and traders (including contact details).

Physical and chemical properties Information on basic physical and chemical properties a) Appearance Form: clear, viscous liquid Colour: light yellow b) Odour No data available c) Odour Threshold No data available d) pH 10.8 – 11.0 at 100 g/l at 20 °C e) Melting point/freezing Melting point/range: -70 °C point f) Initial boiling point and 273 – 275 °C at 988 hPa boiling range g) Flash point 143 °C – closed cup h) Evaporation rate No data available i) Flammability (solid, gas) No data available j) Upper/lower Upper explosion limit: 6.5 %(V) at 64 hPa flammability or Lower explosion limit: 1.1 %(V) at 64 hPa explosive limits k) Vapour pressure 2.7 mmHg at 120 °C 1 mmHg at 25 °C l) Vapour density 5.57 – (Air = 1.0) m) Relative density 0.970 g/cm3 n) Water solubility No data available o) Partition coefficient: n- No data available octanol/water p) Auto-ignition No data available temperature q) Decomposition No data available temperature r) Viscosity No data available s) Explosive properties No data available t) Oxidizing properties No data available

The 2,2′-(Butylimino)diethanol, with the CAS registry number 102-79-4, has the IUPAC name of 2-[butyl(2-hydroxyethyl)amino]ethanol. This chemical is a kind of colourless to light yellow liquid and it is stable but incompatible with strong oxidizing agents.

The physical properties of this chemical are as below: (1)ACD/LogP: 0.88; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): -1.94; (4)ACD/LogD (pH 7.4): -0.37; (5)ACD/BCF (pH 5.5): 1; (6)ACD/BCF (pH 7.4): 1; (7)ACD/KOC (pH 5.5): 1; (8)ACD/KOC (pH 7.4): 4.03; (9)#H bond acceptors: 3; (10)#H bond donors: 2; (11)#Freely Rotating Bonds: 9; (12)Polar Surface Area: 21.7; (13)Index of Refraction: 1.475; (14)Molar Refractivity: 45.9 cm3; (15)Molar Volume: 162.8 cm3; (16)Polarizability: 18.19×10-24 cm3; (17)Surface Tension: 40 dyne/cm; (18)Density: 0.99 g/cm3; (19)Flash Point: 126.7 °C; (20)Enthalpy of Vaporization: 60.09 kJ/mol; (21)Boiling Point: 279.1 °C at 760 mmHg; (22)Vapour Pressure: 0.000499 mmHg at 25°C; (23)Exact Mass: 161.141579; (24)MonoIsotopic Mass: 161.141579; (25)Topological Polar Surface Area: 43.7; (26)Heavy Atom Count: 11; (27)Complexity: 72.5.

The production method of this chemical: 2,2′-azanediyl-bis-ethanol could react with 1-bromo-butane to produce 2,2′-(Butylimino)diethanol. This reaction happens in the presence of the reagent of sodium carbonate.

The use of this chemical: 2,2′-(Butylimino)diethanol could react with 1,1-dimethoxy-2,5-dihydro-1H-silole to produce 9-butyl-6,12-dioxa-9-aza-5-sila-spiro[4.7]dodec-2-ene. This reaction could happen in the presence of the solvent of xylene with its yield of 75%

When you are dealing with this chemical, you should be very careful. For being a kind of corrosive chemical, it may destroy living tissue on contact. And this chemical is irritating to respiratory system and then could causes burns. Therefore, you should wear suitable protective clothing, gloves and eye/face protection. If in case of contact with eyes, rinse immediately with plenty of water and seek medical advice, and if in case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible).

In addition, you could convert the following datas into the molecular structure:

(1)Canonical SMILES: CCCCN(CCO)CCO

(2)InChI: InChI=1S/C8H19NO2/c1-2-3-4-9(5-7-10)6-8-11/h10-11H,2-8H2,1H3

(3)InChIKey: GVNHOISKXMSMPX-UHFFFAOYSA-N

A process for N-butyl-N-(2-nitroxyethyl)nitramine (BuNENA) was investigated: Step 1 involves N-butyl-ethanolamine addition to 98% HNO3 to form a salt mixture; Step 2 is addition of acetic anhydride/acetyl chloride catalyst to the salt mixture. A number of potential intermediates, by-products, and decomposition products from this process were identified/synthesized for use as analytical standards. BuNENA process reaction pathways/mechanisms were elucidated, including the nature of the amine salt solution formed in Step 1. In addition, potential pathways that could account for by-product formation were elaborated. A study of the consumption of acetyl nitrate in Step 2 was undertaken to prevent its build-up.

Background and Study Aims: Recently, tissue adhesive material has been used to improve the initial control of bleeding from huge esophagogastric varices, and to prevent them from rebleeding, in contrast to the conventional sclerotherapy. The present study assessed the value of the combined use of the tissue adhesive substance: N-butyl-2-cyanoacrylate and ethanolamine oleate 5 % for management of bleeding esophagogastric varices.

Patients and Methods: One hundred and fourteen patients with documented active variceal bleeding at the time of endoscopy were alternatively randomized into two groups. The combined therapy group included 58 patients who underwent injection using both cyanoacrylate for large esophageal and gastric varices and a sclerosant agent for remaining varices. The sclerosis, or control, group included 56 patients, who underwent injection with ethanolamine oleate.

Results: This study proved the value of the combined therapy for the initial control of all bleeders (the follow-up period ranged from 12 to 32 months). In the sclerosis group, failure of the initial control of bleeding was reported in two cases (3.6 %). Recurrent bleeding occurred in 8.6 % in the combined therapy group compared to 25 % in the sclerosis group (p < 0.01). Two months of therapy was required to achieve complete eradication of varices in 56.5 % and 21.4 % in the combined therapy and the sclerosis group, respectively. The mean number of sessions needed until the time of evaluation was 2.4 ± 1.1 in the combined therapy group versus 5.1 ± 2.3 sessions in the sclerosis group. The difference showed high statistical significance (p < 0.01). Minor complications occurred less frequently in the combined therapy group. Only one patient in the combined therapy group developed portal pyemia after extension of the tissue adhesive material from the site of injection into the portal vein. This patient died of hepatic failure. The mortality in the combined therapy group was lower than that in the sclerosis group (3.5 % and 8.8 % respectively, p > 0.05).

Conclusion: The combined use of tissue adhesive and sclerosant materials seems to be the best plan for rapid eradication of esophagogastric varices within a short time, requiring the lowest number of injection sessions and involving minor complications and low mortality.

Abstract: The North America N,N-Di(N-Butyl) Ethanolamine market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by the end of 2024 with a CAGR of XX% from 2019 to 2024. This report is an essential reference for who looks for detailed information on North America N,N-Di(N-Butyl) Ethanolamine market. The report covers data on North America markets including historical and future trends for supply, market size, prices, trading, competition and value chain as well as North America major vendors information. In addition to the data part, the report also provides overview of N,N-Di(N-Butyl) Ethanolamine market, including classification, application, manufacturing technology, industry chain analysis and latest market dynamics. Finally, a customization report in order to meet user’s requirements is also available. Key Points of this Report: * The depth industry chain include analysis value chain analysis, porter five forces model analysis and cost structure analysis * The report covers North America and country-wise market of N,N-Di(N-Butyl) Ethanolamine * It describes present situation, historical background and future forecast * Comprehensive data showing N,N-Di(N-Butyl) Ethanolamine capacities, production, consumption, trade statistics, and prices in the recent years are provided * The report indicates a wealth of information on N,N-Di(N-Butyl) Ethanolamine manufacturers * N,N-Di(N-Butyl) Ethanolamine market forecast for next five years, including market volumes and prices is also provided * Raw Material Supply and Downstream Consumer Information is also included * Any other user’s requirements which is feasible for us The N,N-Di(N-Butyl) Ethanolamine market in North America is segmented by countries: * US * Canada * Mexico The reports analysis N,N-Di(N-Butyl) Ethanolamine market in North America by products type: * Type I * Type II * Type III The reports analysis N,N-Di(N-Butyl) Ethanolamine market in North America by application as well: * Application I * Application II * Application III Reasons to Purchase this Report: * Analyzing the outlook of the market with the recent trends and SWOT analysis * Market dynamics scenario, along with growth opportunities of the market in the years to come * Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and non-economic aspects * Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market. * Market value (USD Million) and volume (Units Million) data for each segment and sub-segment * Distribution Channel sales Analysis by Value * Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years * Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players * 1-year analyst support, along with the data support in excel format.

Recently, tissue adhesive material has been used to improve the initial control of bleeding from huge esophagogastric varices, and to prevent them from rebleeding, in contrast to the conventional sclerotherapy. The present study assessed the value of the combined use of the tissue adhesive substance: N-butyl-2-cyanoacrylate and ethanolamine oleate 5% for management of bleeding esophagogastric varices.One hundred and fourteen patients with documented active variceal bleeding at the time of endoscopy were alternatively randomized into two groups. The combined therapy group included 58 patients who underwent injection using both cyanoacrylate for large esophageal and gastric varices and a sclerosant agent for remaining varices. The sclerosis, or control, group included 56 patients, who underwent injection with ethanolamine oleate.This study proved the value of the combined therapy for the initial control of all bleeders (the follow-up period ranged from 12 to 32 months). In the sclerosis group, failure of the initial control of bleeding was reported in two cases (3.6%). Recurrent bleeding occurred in 8.6% in the combined therapy group compared to 25% in the sclerosis group (p < 0.01). Two months of therapy was required to achieve complete eradication of varices in 56.5% and 21.4% in the combined therapy and the sclerosis group, respectively. The mean number of sessions needed until the time of evaluation was 2.4 +/- 1.1 in the combined therapy group versus 5.1 +/- 2.3 sessions in the sclerosis group. The difference showed high statistical significance (p < 0.01). Minor complications occurred less frequently in the combined therapy group. Only one patient in the combined therapy group developed portal pyemia after extension of the tissue adhesive material from the site of injection into the portal vein. This patient died of hepatic failure. The mortality in the combined therapy group was lower than that in the sclerosis group (3.5% and 8.8% respectively, p > 0.05).The combined use of tissue adhesive and sclerosant materials seems to be the best plan for rapid eradication of esophagogastric varices within a short time, requiring the lowest number of injection sessions and involving minor complications and low mortality.

Abstract Global N,N-Di(N-Butyl) Ethanolamine (CAS 102-81-8) Market is accounted for xx USD million in 2019 and is expected to reach xx USD million by 2026 growing at a CAGR of xx% during the forecast period. The report offers in-depth insights, revenue details, and other vital information regarding the global N,N-Di(N-Butyl) Ethanolamine (CAS 102-81-8) market and the various trends, drivers, restraints, opportunities, and threats in the target market till 2026. N,N-Di(N-Butyl) Ethanolamine (CAS 102-81-8) Market report covers size, share and forecast (value and volume) by regions, top players, product types and applications, with historical data along with forecast from 2019 to 2026; The report covers an in depth description, competitive scenario, wide product portfolio of key vendors and business strategy adopted by competitors along with their SWOT analysis, revenue, sales and Porter’s Five Forces Analysis. By geography, this market has been segregated into five regions with revenue and growth rate of N,N-Di(N-Butyl) Ethanolamine (CAS 102-81-8) from 2013 to 2026, • North America (U.S., Canada, Mexico) • Europe (U.K., France, Germany, Spain, Italy, Central & Eastern Europe, CIS) • Asia Pacific (China, Japan, South Korea, ASEAN, India, Rest of Asia Pacific) • Latin America (Brazil, Rest of L.A.) • Middle East And Africa(Turkey, GCC, Rest of Middle East) The major players operating into N,N-Di(N-Butyl) Ethanolamine (CAS 102-81-8) Market include: Company I Company II Company III This report segments the Global N,N-Di(N-Butyl) Ethanolamine (CAS 102-81-8) Market as follows: Global N,N-Di(N-Butyl) Ethanolamine (CAS 102-81-8) Market: Type Segment Analysis Product Type I Product Type II Product Type III Global N,N-Di(N-Butyl) Ethanolamine (CAS 102-81-8) Market: Application Segment Analysis Application I Application II Application III There are 13 chapters to put on view for N,N-Di(N-Butyl) Ethanolamine (CAS 102-81-8) Market: Chapter 1: Market Overview, Drivers, Restraints and Opportunities, Segmentation overview Chapter 2: Market competition by Manufacturers Chapter 3: Production by Regions Chapter 4: Consumption by Regions Chapter 5: Production, By Types, Revenue and Market share by Types Chapter 6: Consumption, By Applications, Market share (%) and Growth Rate by Applications Chapter 7: Complete profiling and analysis of Manufacturers Chapter 8: Manufacturing cost analysis, Raw materials analysis, Region-wise manufacturing expenses Chapter 9: Industrial Chain, Sourcing Strategy and Downstream Buyers Chapter 10: Marketing Strategy Analysis, Distributors/Traders Chapter 11: Market Effect Factors Analysis Chapter 12: Market Forecast Chapter 13: N,N-Di(N-Butyl) Ethanolamine (CAS 102-81-8) Research Findings and Conclusion, Appendix, methodology and data source Data type include capacity, production, market share, price, revenue, cost, gross, gross margin, growth rate, consumption, import, export have been determined using secondary sources and verified primary sources. Industry chain, manufacturing process, cost structure, marketing channel are also analyzed in this report. Industry Chain Analysis Raw Material and Suppliers Equipment and Suppliers Manufacturing Process Manufacturing Cost Structure Manufacturing Plants Distribution Analysis

Mono etanol amin, 2-Amino etanol, 2-Hidroksi etil amin, Olamin gibi isimlendirmeleri de mevcuttur. Mono etanol amin, MEA olarak ksaltmas da kullanlmaktadr.

Mono etanol amin, zirai kimyasallarn yapsnda bulunur. Mono etanol amin, ilaç ürün formülasyonlarnda yaptrc olarak kullanlmaktadr. Mono etanol amin, anyonik emülsifiyerler için nötralize edici ajanlar olarak kullanlr. Mono etanol amin, detejanlarda, araba ykama ampuanlarn yapsna katlr. Mono etanol amin, yüzey aktif madde ve korozyon önleyici olarak kullanlmaktadr.

N-Bütildietanolamin (N-n-butildietanolamin) bir üçüncül amindir. N ikameli bir dietanolamin ligand olarak ilev görür. Krom (II) ve lantanit (III) / nadir toprak tuzlar (Ln = La, Ce, Pr, Nd, Sm, Eu, Gd, Tb, Dy, Ho, Er, Tm, Yb, Lu, Y) ile reaksiyona girer. üç dizi izo-yapsal 1: 1 3d (Cr (III)) / 4f (Ln (III)) koordinasyon kümesi bileikleri salamak için koliganlarn varl.

Aadaki komplekslerin sentezinde N-Bütildietanolamin (H2bdea, N-n-butildietanolamin) kullanlmtr (Hdnba = 3,5-dinitrobenzoik asit, Hpta = p-toluik asit, H2tpa = tereftalik asit):

• yeni mononükleer [Cu (Hbdea) 2] · 2Hdnba, dinükleer [Cu2 (µ-Hbdea) 2 (N3) 2] ve [Cu2 (µ-Hbdea) 2 (pta) 2] · 2H2O [1]

• 1D polimerik [Cu2 (µ-Hbdea) 2 (µ-tpa)] n · 2nH2O bakr (II) bileikleri [1]

• tetranükleer 3d-4f tek moleküllü mknats (SMM) kompleksleri [2]

Tanm: N-Bütildietanolamin, amin benzeri bir kokuya sahip renksiz ila sar bir svdr. Her oranda su ile karabilir.

E anlamllar: BDEA, N-Butildietanolamin, Butildietanolamin, Butildietanolamin, N, N-Bis (2-hidroksietil) Butilamin, N-Butil-2,2′-iminodietanol, N-Butildietanolamin, N-Butyliminodietanol

Uygulamalar: laç ve Fotografik kimya üretiminde kullanlan ara ürün

Fiziksel ve kimyasal özellikler Temel fiziksel ve kimyasal özellikler hakknda bilgi a) Görünüm Form: berrak, viskoz sv Renk: açk sar b) Koku uygun veri yoktur c) Koku Eii Uygun veri yoktur d) pH 10,8 – 11,0 100 g / l at 20 ° C e) Erime noktas / donma Erime noktas / aral: -70 ° C noktas f) lk kaynama noktas ve 988 hPa kaynama aralnda 273 – 275 ° C g) Parlama noktas 143 ° C – kapal kap h) Buharlama hz Veri yok mevcut i) Tutuabilirlik (kat, gaz) Kullanlabilir veriler yok j) Üst / alt Üst patlama snr: 64 hPa alevlenebilirlikte% 6,5 (V) veya Alt patlama snr: 64 hPa patlama snrlarnda% 1,1 (V) k) Buhar basnc 2,7 mmHg 120 ° C’de 1 mmHg, 25 ° C’de l) Buhar younluu 5,57 – (Hava = 1,0) m) Bal younluk 0,970 g / cm3 n) Su çözünürlüü Kullanlabilir veriler yok o) Dalm katsays: n- Kullanlabilir veri yok oktanol / su p) Kendiliinden tutuma mevcut veri yok scaklk q) Bozunma mevcut veri yok scaklk r) Viskozite Uygun veri yok s) Patlayc özellii s uygun veri yok t) Oksitleyici özellikler Veri yok

N – butil – N- (2 – nitroksietil) nitramin (BuNENA) için bir proses aratrld: Adm 1, bir tuz karm oluturmak için% 98 HNO3’e N – butil – etanolamin ilavesini içerir; Adm 2, tuz karmna asetik anhidrit / asetil klorür katalizörünün eklenmesidir. Bu süreçteki bir dizi potansiyel ara ürün, yan ürün ve ayrma ürünleri analitik standartlar olarak kullanlmak üzere tanmlanm / sentezlenmitir. Adm 1’de oluturulan amin tuzu çözeltisinin doas da dahil olmak üzere BuNENA ilem reaksiyon yollar / mekanizmalar açklanmtr. Ek olarak, yan ürün oluumunu açklayabilecek potansiyel yollar ayrntl olarak açklanmtr. Olumasn önlemek için Adm 2’de asetil nitrat tüketimi üzerine bir çalma yaplmtr. Arka Plan ve Çalma Amaçlar: Son zamanlarda, geleneksel skleroterapinin aksine, büyük özofagogastrik varislerden kanamann ilk kontrolünü iyiletirmek ve bunlarn yeniden kanamasn önlemek için doku yapkan materyali kullanlmtr. Bu çalma, özofagogastrik varis kanamalarnn yönetimi için doku yapkan maddesinin kombine kullanmnn deerini deerlendirdi: N-butil-2-siyanoakrilat ve etanolamin oleat% 5.

BÜTLETANOLAMN

Hzl Detaylar

Bütiletanolamin CAS No:

111-75-1

Bütiletanolamin Dier simler:

Butil (2-hidroksieti1) amin

Bütiletanolamin Snf standart:

Endüstriyel snf, Petrol endüstrisi, korozyon inhibitörleri

Bütiletanolamin Saflk:

% 99% min

Bütiletanolamin Görünüm:

Renksiz

Bütiletanolamin Uygulama:

Petrol endüstrisi, korozyon inhibitörleri

Bütiletanolamin Test:

Min. 99% (GC ile)

Bütiletanolamin Damtma Aral:

190 C-206 C

Bütiletanolamin Su Içerii:

Wt tarafndan % 0.5 maksimum %

Bütiletanolamin Renk:

50 APHA max

Bütiletanolamin Dier özellikler (fiziksel)

Donma noktas:-2OC

Bütiletanolamin Krlma Indeksi, n20D: 1.444

Bütiletanolamin Younluklu 25O: 0.891 g/ml

Uygulamalar Petrol endüstrisi, korozyon inhibitörleri

MONO ETANOL AMN (MEA)

Cas No 141-43-5

EINECS No 205-483-3

Kimyasal Formülü C2H7NO

Görünüm Renksiz

Saflk(%) 99.88

Younluk (Kg/Litre) 1.113

Parlama Noktas, °C 85

Kaynama Noktas, °C 170

Güvenlik Formu(Msds)

Mono etanol amin, 2-Amino etanol, 2-Hidroksi etil amin, Olamin gibi isimlendirmeleri de mevcuttur. Mono etanol amin, MEA olarak ksaltmas da kullanlmaktadr.

Bütiletanolaminin Özellikleri

Bütiletanolamin lgili Kategoriler: Bütiletanolamin: Amino Alkoller, Yap Talar, Kimyasal Sentez, Organik Yap Talar, Oksijen Bileikleri Daha fazla …

Bütiletanolamin 100 Kalite Seviyesi

test ?98%

Bütiletanolamin n20 / D 1.444 krlma indisi (lit.)

bp Bütiletanolamin 198-200 ° C (lit.)

25 ° C’de Bütiletanolamin younluu 0.891 g / mL (lit.)

Bütiletanolamin CCILNCCO SMILES dizisi

InChI 1S / C6H15NO / c1-2-3-4-7-5-6-8 / h7-8H, 2-6H2,1H3

Bütiletanolamin açklamas

Bütiletanolaminin genel tanm

Bütiletanolamin, bir -OH grubuna sahip ikincil bir amindir.

Bütiletanolamin Uygulamas

4-alkilamino-2,5,6-trimetil -7- (2,4,6-trimetilfenil) pirolo [2,3-d] pirimidinlerin sentezi için 2- (bütilamino) etanol (N-Bütiletanolamin) kullanlabilir. [1] ve N-butil-N- (2-nitroksietil) nitramin (BuNENA). [2]

Bütiletanolaminin Kimyasal ve Fiziksel Özellikleri

4.1 Bütiletanolaminin Hesaplanan Özellikleri

Özellik Ad Özellik Deeri Referans

Bütiletanolaminin Molekül Arl 117.19 g / mol 2.1 (sürüm 2019.06.18)

XLogP3-AA 0.4 XLogP3 3.0 ile hesaplanr (sürüm 2019.06.18)

Cactvs 3.4.6.11 (sürüm 2019.06.18) ile hesaplanan Bütiletanolamin 2’nin Hidrojen Ba Donör Says

Cactvs 3.4.6.11 (sürüm 2019.06.18) ile hesaplanan Bütiletanolamin 2’nin Hidrojen Bond Alc Says

Butacthanolamine 5’in Dönebilen Ba Says Cactvs 3.4.6.11 (sürüm 2019.06.18)

Bütiletanolaminin Tam Kütlesi 117.115364 g / mol 2.1 (sürüm 2019.06.18)

Bütiletanolamin Monoizotopik Kütlesi 117.115364 g / mol 2.1 (sürüm 2019.06.18)

Bütiletanolamin Topolojik Polar Yüzey Alan 32.3 Å² C

Bütiletanolamin Ar Atom Says 8

Bütiletanolaminin Resmi Yükü 0

Bütiletanolaminin karmakl 39.5

Bütiletanolaminin zotop Atom Says 0

Bütiletanolamin Tanml Atom Stereo Merkezi Saylar 0

Bütiletanolaminin Tanmsz Atom Stereo Merkezi Saylar 0

Bütiletanolamin Tanml Bond Stereo Merkezci Says 0

Bütiletanolamin Tanmsz Bond Stereo Merkezi Say

Bütiletanolaminin Kovalent Balanm Birim Says 1

Bileik Bütiletanolamin Kanonikletirildi Evet

N-BUTYLETHANOLAMINE (BTLETANOLAMN)

Table of Contents

N-BUTYLETHANOLAMINE (BTLETANOLAMN)

Explore:

EXPLORE

INFORMATIONS

NEWSLETTER